Assistant Professor of Medicine
Pulmonology
Dr. Joshua M. Diamond, MD
|
|
Give Review
Joshua Diamond practices Pulmonology. He graduated from University of Rochester School of Medicine and Dentistry. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Joshua M. Diamond has written publications. He has 28 publications published with PubMed. The lastest publication is: 'The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyper...' He is registered with Medicare and accepts Medicare payments.
Publications
- The relationship between plasma lipid peroxidation products and primary graft dysfunction after Lung transplantation is modified by donor smoking and reperfusion hyper...
- Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation.
- Viral Metagenomics Reveal Blooms of Anelloviruses in the Respiratory Tract of Lung Transplant Recipients.
- Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after Lung transplantation.
- Lung size mismatch and primary graft dysfunction after bilateral Lung transplantation.
- Body Composition and Mortality after Adult Lung Transplantation in the United States.
- Plasma complement levels are associated with primary graft dysfunction and mortality after Lung transplantation.
- Mechanical Ventilation after Lung Transplantation. It's Time for a Trial.
- Cognitive Function, Mental Health, and Health-related Quality of Life after Lung Transplantation.
- Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after Lung transplantation.
- Donor Age and Early Graft Failure After Lung Transplantation: A Cohort Study.
- Gene Set Enrichment Analysis Identifies Key Innate Immune Pathways in Primary Graft Dysfunction After Lung Transplantation.
- Elevated plasma angiopoietin-2 levels and primary graft dysfunction after Lung transplantation.
- Early Plasma Soluble Receptor for Advanced Glycation End-Product Levels Are Associated With Bronchiolitis Obliterans Syndrome.
- Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation.
- Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after Lung transplantation.
- Variation in PTX3 is Associated With Primary Graft Dysfunction After Lung Transplantation.
- Lung-enriched Organisms and Aberrant Bacterial and Fungal Respiratory Microbiota following Lung Transplant.
- A panel of Lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after Lung transplantation.
- Innate lymphoid cells promote Lung-tissue homeostasis after infection with influenza virus.
- Fluorescence competition and optical melting measurements of RNA three-way multibranch loops provide a revised model for thermodynamic parameters.
- The contribution of airway and Lung tissue ischemia to primary graft dysfunction.
- Severe venous and lymphatic obstruction after single-chamber pacemaker implantation in a patient with chest radiation therapy.
- Recurrent spontaneous Pneumothorax as the presenting sign of the Birt-Hogg-Dubé syndrome.
- Visual vignette. Diagnosis: thyroid acropachy, the rare musculoskeletal manifestation of Graves' hyperthyroidism.
- Lung transplantation for Chronic obstructive pulmonary disease: special considerations.
- Obesity and primary graft dysfunction after Lung transplantation: the Lung Transplant Outcomes Group Obesity Study.
Schools
University Of Rochester
Procedures Preformed
- Bronchoscopy
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Bronchiectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania -
University of Pennsylvania Health System -
University of Rochester School of Medicine and Dentistry -
University of Rochester
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1679636021 | |
| NPPES Provider LastName | DIAMOND | |
| NPPES Provider FirstName | JOSHUA | |
| NPPES Provider ZIPCode | 191044206 | |
| NPPES Provider State | PA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 61.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679636021 |
| Last Name Of The Provider | DIAMOND |
| First Name Of The Provider | JOSHUA |
| View All |
Similar Doctors
|
|
Dr. Jonathan Galli, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hilary E. Faust, MD |
|
|
Dr. Bruce B. Dershaw, MD |
|
Dr. Muhammad K. Athar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Indira Gurubhagavatula, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Audreesh Banerjee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ilene Rosen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul N. Lanken, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Barry D. Fuchs, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Gilbert D'Alonzo, MD
This Doctor is OpenDoctor Recommended.
|